BIOMAT Database Logo BIOMAT Database Logo

[Endocrinological aspects of the dopaminergic control of somatotropin in patients with acromegaly]. 1977

G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006003 Glycogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)

Related Publications

G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Somatotropin: endocrinological aspects].
September 1988, Tijdschrift voor diergeneeskunde,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
June 1990, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Changes in the neuroendocrine control of somatotropin secretion in acromegaly].
December 1987, Recenti progressi in medicina,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Studies of hypothalamic control of somatotropin incretion in acromegaly].
December 1973, Folia endocrinologica,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
Endocrinological evaluation of acromegaly.
September 1998, Journal of neurosurgery,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Somatotropin in the blood in acromegaly].
October 1956, Nordisk medicin,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
December 1973, Folia endocrinologica,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Behavior of somatotropin secretion in subjects with acromegaly].
January 1971, Archivio "E. Maragliano" di patologia e clinica,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
Effect of triiodothyronine on thyroliberin-induced somatotropin release in patients with acromegaly.
January 1977, Endokrynologia Polska,
G Gragnoli, and G Martinelli, and I Tanganelli, and A M Signorini, and A Pallassini
[Autoregulation of somatotropin secretion in acromegaly].
December 1976, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!